tag:blogger.com,1999:blog-4241416962008169508.post7892842476267697930..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: Truly Exciting News! Merck's Next Gen Osteoporosis Candidate -- Early NDA Filing With FDAUnknownnoreply@blogger.comBlogger3125tag:blogger.com,1999:blog-4241416962008169508.post-49419112314020038072013-02-01T15:48:49.634-05:002013-02-01T15:48:49.634-05:00Well -- in a stunning reversal -- Merck just annou...Well -- in a stunning reversal -- Merck just announced that it would need additional safety and efficacy data before it would submit an NDA to FDA on this candidate.<br /><br />My full <a href="http://shearlingsplowed.blogspot.com/2013/02/breaking-full-year-delay-after-positive.html" rel="nofollow">report is here</a>, from the monring call.<br /><br />That puts a mid-2013 submission to FDA out of reach. Merck now says the FDA submission will come in 2014.<br /><br />It's costing Merck about $1.30 a share in NYSE price quotation, on double normal volumes, this afternoon. Ugh.<br /><br />NamasteCondorhttp://shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-33379354357772454782012-07-17T08:44:41.430-04:002012-07-17T08:44:41.430-04:00I do hear you, Anon.
Merck Frosst was an R&D ...I do hear you, Anon.<br /><br />Merck Frosst was an R&D group with a stellar reputation. Then came the battle-axe-weilding MBAs. . . .<br /><br />NamasteCondorhttp://shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-6571661642892659142012-07-12T11:02:11.488-04:002012-07-12T11:02:11.488-04:00At the risk of sounding like a petulant child, the...At the risk of sounding like a petulant child, the team you are giving kudos to "i.e. Frazier et al", also made the questionable business decision of closing the research site responsible for the discovery of Odenacatib (i.e. Merck Frosst), which coincidentally, also discovered the other Phase III asset "Laropiprant" you highlighted in an ealier post. That said, I must confess that I do enjoy reading your blog and your extremely fair coverage of this once admirable company.Anonymousnoreply@blogger.com